Newsroom Careers Contact Us


Empowering the fight against cancer

We are dedicated to making quality medication affordable globally. We focus on expanding one of our main portfolio, oncology, using advanced R&D to develop medicines for highly regulated markets and broadening our global impact.


Oncology Portfolio

Novugen enhances in achieving the desired quality of our products with advanced R&D and systematic Quality by Design (QbD) approach.

  • Prostate cancer
  • Breast cancer
  • Lung Cancer
  • Blood cancer
  • Renal cancer
  • Colorectal cancer
  • Ovarian & Uterine cancer
  • Cervical cancer
  • Thyroid cancer
  • Liver cancer
  • Pancreatic cancer
  • Gastrointestinal stromal tumours (GIST)
  • Immunosuppressants (Rheumatology & Organ Transplants)

High containment FDF manufacturing facility

Our oncology plant is strategically located near the Kuala Lumpur International Airport at Enstek Park, Malaysia and holds unique features:

  • Southeast Asia's only USFDA-Approved manufacturing facility to manufacture high potent oncology products.
  • Completely automated, Respirator-free, OEB 5 category high-containment plant
  • Designed by international engineering firm following CbD principles (Containment by design)
  • Environment friendly, 100% zero-discharge facility
  • Multi-products, versatile facility with flexibility to handle varied batch sizes – few grams to several kgs in single lot. (0.2kg to 60kg)


High containment API manufacturing facility

Built as a multiproduct commercial manufacturing facility to conduct commercial cGMP manufacturing of APIs for both clinical trial supplies and commercial products for global markets. The facility is designed for phase-wise expansion to meet global demand of oncology APIs.